Before the era of preoperative radiochemotherapy became the standard treatment, several prognostic factors for predicting recurrence were reported [18, 19], such as tumor size, pathological T and N stages, histologic grade, vascular invasion, and carcinoembryonic antigen (CEA) level. Here, CEACAM5 is linked to neoplasm.